Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V [Breast Cancer]

Conclusion Patients with ER-positive breast cancer maintain a significant recurrence rate during extended follow up. Strategies for follow up and treatments to prevent recurrences may be most efficiently applied and studied in patients with ER-positive disease followed for a long period of time.

http://jco.ascopubs.org/cgi/content/short/34/9/927?rss=1

Source: Journal of Clinical Oncology - March 9, 2016 Category: Cancer & Oncology Authors: Colleoni, Sun, Price, Karlsson, Forbes, Thurlimann, Gianni, Castiglione, Gelber, Coates, Goldhirsch Tags: Chemotherapy, Hormonal Therapy Breast Cancer Source Type: research